Smith & Nephew (SNN) Cash from Operations (2013)

Smith & Nephew (SNN) posted quarterly Cash from Operations of 246000000.0 for Q4 2013.

Smith & Nephew (SNN) Cash from Operations (2013) Analysis & Trends

Smith & Nephew (SNN) has reported Cash from Operations for 1 consecutive years, with 246000000.0 the latest figure, recorded in Q4 2013.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 1.32 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 581.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 2.57 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 348.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 43.80 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 525.60 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 220.10 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 290.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Steris 20.59 Bn 20.16 Bn 697.10 Mn 335.40 Mn

Historic Data

Download Data
DateValue
Dec 31, 2013 246.00 Mn
Dec 31, 2013 246.00 Mn